Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Mitchell Mcleod Pugh & Williams Inc.

Mitchell Mcleod Pugh & Williams Inc. lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.1% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 503 shares of the medical equipment provider’s stock after purchasing an additional 20 shares during the period. Mitchell Mcleod Pugh & Williams Inc.’s holdings in Intuitive Surgical were worth $247,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in ISRG. Norden Group LLC grew its holdings in shares of Intuitive Surgical by 32.4% in the first quarter. Norden Group LLC now owns 957 shares of the medical equipment provider’s stock valued at $382,000 after purchasing an additional 234 shares in the last quarter. Empowered Funds LLC grew its holdings in Intuitive Surgical by 5.3% during the 1st quarter. Empowered Funds LLC now owns 7,093 shares of the medical equipment provider’s stock worth $2,831,000 after acquiring an additional 354 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its holdings in Intuitive Surgical by 9.8% during the 1st quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 921 shares of the medical equipment provider’s stock worth $368,000 after acquiring an additional 82 shares in the last quarter. Atomi Financial Group Inc. grew its holdings in Intuitive Surgical by 19.6% during the 1st quarter. Atomi Financial Group Inc. now owns 867 shares of the medical equipment provider’s stock worth $346,000 after acquiring an additional 142 shares in the last quarter. Finally, Concurrent Investment Advisors LLC grew its holdings in Intuitive Surgical by 29.6% during the 1st quarter. Concurrent Investment Advisors LLC now owns 2,799 shares of the medical equipment provider’s stock worth $1,117,000 after acquiring an additional 639 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Intuitive Surgical stock traded up $12.17 during trading hours on Friday, reaching $536.45. 1,427,803 shares of the stock were exchanged, compared to its average volume of 1,307,284. The stock has a market cap of $191.07 billion, a P/E ratio of 86.25, a P/E/G ratio of 5.07 and a beta of 1.39. Intuitive Surgical, Inc. has a 52-week low of $269.49 and a 52-week high of $538.49. The firm’s 50 day moving average is $493.92 and its 200 day moving average is $451.73.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. Equities research analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insiders Place Their Bets

In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of the company’s stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the transaction, the chief executive officer now owns 24,219 shares in the company, valued at approximately $12,391,166.97. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, EVP Brian Edward Miller sold 2,553 shares of the company’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the transaction, the executive vice president now directly owns 7,066 shares of the company’s stock, valued at $3,638,990. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of the company’s stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the transaction, the chief executive officer now directly owns 24,219 shares in the company, valued at approximately $12,391,166.97. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 68,246 shares of company stock worth $33,839,308. 0.90% of the stock is owned by insiders.

Analysts Set New Price Targets

Several research analysts have commented on ISRG shares. Piper Sandler reiterated an “overweight” rating and set a $538.00 price target (up previously from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Raymond James boosted their price target on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a report on Monday, October 14th. Barclays upped their target price on shares of Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a report on Thursday, July 18th. Wells Fargo & Company upped their target price on shares of Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a report on Friday, October 18th. Finally, Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $513.74.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.